Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
申请人:Anderson R. David
公开号:US20050137220A1
公开(公告)日:2005-06-23
A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject a beta-carboline MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.
CYBOPOB, N. N.;VINOGRAD, L. X.;TURCHIN, K. F.;ILINA, G. N.;VIGDORCHIK, M.+, XIMIYA GETEROTSIKL. SOEDIN., 1984, N 8, 1093-1100
作者:CYBOPOB, N. N.、VINOGRAD, L. X.、TURCHIN, K. F.、ILINA, G. N.、VIGDORCHIK, M.+
DOI:——
日期:——
[EN] BETA-CARBOLINE COMPOUNDS AND ANALOGUES THEREOF AND THEIR USE AS MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS<br/>[FR] COMPOSES DE BETA-CARBOLINE AINSI QUE LEURS ANALOGUES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PROTEINE KINASE-2 ACTIVEE PAR PROTEINE KINASE ACTIVEE PAR DES MITOGENES
申请人:PHARMACIA CORP
公开号:WO2005009370A2
公开(公告)日:2005-02-03
Novel methods and compositions are described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject. The method involves administering to the subject a beta-carboline MK-2 inhibiting compound, or a pharmaceutically acceptable salt, or isomer thereof. The novel compositions are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 and analogues thereof. Pharmaceutical compositions and kits that include these compounds are also described.